VC-backed Clearside Biomedical files for IPO
Alpharetta, Georgia-based Clearside Biomedical Inc, which focuses on treating blinding diseases of the eye, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. However, the company plans on trading the stock on the NASDAQ under the ticker symbol "CLSD." RBC Capital Markets and Stifel will serve as the lead underwriters. Clearside's backers include Aju IB Investment, Cormorant Asset Management, Perceptive Advisors and Rock Springs Capital Management.
11 January 2016•2 mins read
